University of Florida Researchers Develop Rapid Urine Test for Prostate Cancer
The noninvasive method uses paper spray and mass spectrometry to identify disease biomarkers in less than 30 seconds.
Category: Prostate
Prostate
Latest
Prostate
Latest
Urine-Based Liquid Biopsy Shows High Sensitivity for Prostate Cancer Detection
A new study validates a machine-learning platform that detects prostate cancer through biochemical patterns in urine samples.
Prostate
Latest
Prostate-specific Antigen Testing in England Shows Concerning Patterns of Overuse
A study of over 10 million men reveals frequent testing of patients unlikely to benefit, raising questions about current screening practices.
Landmark Longitudinal Prostate Cancer Study Released
A new study confirms Cleveland Diagnostics’ IsoPSA test effectively differentiates between low- and high-risk prostate cancer patients.
Read More
Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in SEER Specialized Database Release
Decipher Prostate Genomic Classifier data is included in a new SEER Program database, enabling the study of prostate cancer outcomes.
Read More
Lynx Dx Launches At-Home Prostate Cancer Test
Lynx Dx announced at-home availability of a urine-based prostate cancer test that eliminates the need for a digital rectal exam.
Read More
Urine Test Detects Prostate Cancer and Reduces Unnecessary Biopsies
A new study validated a urine test that offers a less invasive, more accurate alternative to traditional prostate cancer screening.
Read More
Why Genomic Tests for Prostate Cancer Need Better Data
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Read More
New Blood Test Predicts Prognosis for Advanced Prostate Cancer Patients
The AR-ctDETECT test identifies circulating tumor DNA in advanced prostate cancer patients, providing critical insights for prognostication.
Read More
Researchers Discover Genetic Marker to Identify Aggressive Prostate Cancers Early
A genetic variant in the PSA gene may help improve prostate cancer diagnostics by distinguishing between aggressive and non-aggressive types.
Read More
Early Blood Test Predicts Survival in Patients with Metastatic Prostate Cancer
A study shows that measuring CTCs at the time of metastatic prostate cancer diagnosis can predict survival and guide treatment decisions.
Read More
How Prostate Cancer Screening Advancements Are Reducing Overtreatment
A new prostate cancer screening method could help better predict which patients need to undergo a biopsy, reducing unnecessary procedures.
Read More
GRAIL’s Galleri Test Shows High Accuracy to Detect Aggressive Prostate Cancers
GRAIL’s Galleri multi-cancer early detection test demonstrates strong performance in preferentially identifying aggressive prostate cancers.
Read More
Researchers Discover Novel Nanoparticles in Blood that Could Transform Cancer Diagnosis
A newly discovered class of RNA molecules in extracellular vesicles could serve as biomarkers for non-invasive cancer diagnosis.
Read More
Prostate Cancer: Is AI the Answer to Limit Need of Biopsies?
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Read More
Why Men Should be Screened for the ‘Breast Cancer Gene’
Studies indicate men with BRCA1 and BRCA2 mutations face significant cancer risks, prompting new national screening guidelines.
Read More
Prostate Cancer Blood Test Equally Effective Across Ethnic Groups
A prostate cancer test using protein and genetic markers improves diagnosis accuracy and reduces unnecessary procedures across ethnic groups.
Read More
Prostate Cancer Risks for Transgender Women on Hormone Therapy
A study warns that transgender women on hormone therapy may have artificially low PSA levels, potentially delaying prostate cancer diagnosis.
Read More